Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RE-LATED AF
2013-005364-26Phase 2Terminated
- Sponsor
- University Medical Center Mainz
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Atrial fibrillation (AFib) and atrial flutter (AFL) comparing Dabigatran arm with Phenprocoumon arm (2 arms). Primary endpoint: Time to complete left atrial appendage thrombus resolution. Started Apr 2014; status: terminated.
02
Drugs
dabigatranphenprocoumon
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on 2013-005364-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005364-26.